Literature DB >> 10344006

Thrombophilia: a genetic predisposition to thrombosis.

R A Sacher1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10344006      PMCID: PMC2194308     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


× No keyword cloud information.
  25 in total

1.  Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V.

Authors:  J Voorberg; J Roelse; R Koopman; H Büller; F Berends; J W ten Cate; K Mertens; J A van Mourik
Journal:  Lancet       Date:  1994-06-18       Impact factor: 79.321

2.  Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.

Authors:  B Zöller; P J Svensson; X He; B Dahlbäck
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

3.  Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?

Authors:  M den Heijer; H J Blom; W B Gerrits; F R Rosendaal; H L Haak; P W Wijermans; G M Bos
Journal:  Lancet       Date:  1995-04-08       Impact factor: 79.321

4.  Anticoagulant protein C pathway defective in majority of thrombophilic patients.

Authors:  J H Griffin; B Evatt; C Wideman; J A Fernández
Journal:  Blood       Date:  1993-10-01       Impact factor: 22.113

5.  Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase.

Authors:  S S Kang; J Zhou; P W Wong; J Kowalisyn; G Strokosch
Journal:  Am J Hum Genet       Date:  1988-10       Impact factor: 11.025

6.  Heterozygous type I plasminogen deficiency is associated with an increased risk for thrombosis: a statistical analysis in 20 kindreds.

Authors:  M T Sartori; G M Patrassi; P Theodoridis; A Perin; F Pietrogrande; A Girolami
Journal:  Blood Coagul Fibrinolysis       Date:  1994-12       Impact factor: 1.276

7.  Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.

Authors:  B Dahlbäck; M Carlsson; P J Svensson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

8.  The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population.

Authors:  J C Souto; I Coll; D Llobet; E del Río; A Oliver; J Mateo; M Borrell; J Fontcuberta
Journal:  Thromb Haemost       Date:  1998-09       Impact factor: 5.249

9.  High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)

Authors:  F R Rosendaal; T Koster; J P Vandenbroucke; P H Reitsma
Journal:  Blood       Date:  1995-03-15       Impact factor: 22.113

10.  Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study)

Authors:  T Koster; F R Rosendaal; E Briët; F J van der Meer; L P Colly; P H Trienekens; S R Poort; P H Reitsma; J P Vandenbroucke
Journal:  Blood       Date:  1995-05-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.